Shares of Teleflex Inc. TFX slipped 4.57% to $132.75 Friday, on what proved to be an all-around great trading session for the ...

Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...

Short selling involves borrowing shares and then selling them at current market prices. In the successful version of the ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and ...

Teleflex faced multiple downgrades from investment banks on Friday after the company reported disappointing fourth-quarter ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Teleflex (TFX – Research Report). The company’s ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Teleflex vascular access (24% of sales) is a no-moat business, in our view. While Teleflex leads the market for central venous catheters, or CVC, tubes that are connected to veins and used to deliver ...

Teleflex Incorporated announced a plan to separate the company’s urology, acute care, and original equipment manufacture ...

What Happened? Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company ...